Discontinued — last reported Q3 '25
Cencora Estimated Litigation Liability, Noncurrent decreased by 0.3% to $3.86B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10.0%, from $4.28B to $3.86B. Over 5 years (FY 2020 to FY 2025), Estimated Litigation Liability, Noncurrent shows a downward trend with a -8.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase signals higher expected legal costs or adverse developments in ongoing litigation.
This represents the estimated liability for legal proceedings and settlements that are expected to be resolved beyond th...
Highly relevant for McKesson, Cencora, and Cardinal Health due to shared industry-wide litigation risks.
other_litigation_reserve_noncurrent| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.27B | $5.96B | $5.91B | $5.94B | $5.91B | $5.46B | $5.46B | $5.45B | $5.46B | $5.06B | $4.73B | $4.72B | $4.70B | $4.30B | $4.30B | $4.28B | $4.28B | $3.88B | $3.87B | $3.86B |
| QoQ Change | — | -4.9% | -0.8% | +0.4% | -0.4% | -7.6% | +0.0% | -0.3% | +0.1% | -7.2% | -6.5% | -0.3% | -0.5% | -8.5% | +0.0% | -0.3% | +0.0% | -9.4% | -0.3% | -0.3% |
| YoY Change | — | — | — | — | -5.8% | -8.4% | -7.6% | -8.2% | -7.7% | -7.3% | -13.4% | -13.4% | -13.9% | -15.1% | -9.2% | -9.2% | -8.8% | -9.7% | -10.0% | -10.0% |